Last reviewed · How we verify

NCT06539078: AGAMEMNON

Exercise as a Countermeasure Against the Effects of Ageing on Muscle Mitochondria, Diffusive Oxygen Transport and Muscle Volume

Recruiting now Last updated 2 August 2024
What this trial tests

trial testing Maximal exercise test in Aging in 60 participants. Currently enrolling.

Timeline
25 March 2024
Primary endpoint
1 December 2025
1 December 2026

Quick facts

Lead sponsorVU University of Amsterdam
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment60
Start date25 March 2024
Primary completion1 December 2025
Estimated completion1 December 2026
Sites1 location across Netherlands

Drugs / interventions tested

Conditions studied

Sponsor

VU University of Amsterdam

Who can join

Adults 18 to 65, any sex, with Aging. Healthy volunteers can join.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Sponsor's own description

Healthy ageing is associated with the loss of muscle mass and physical function. As a result, older people are limited in their independence. The aging of muscles typically begins around the age of 30. From this age onward, muscle strength, muscle mass, and the maximum oxygen uptake of muscles decrease. The reasons for this are not entirely clear, but it seems to be partly related to how oxygen moves from our blood vessels to the muscles and how muscles burn energy. The precise role of age and physical fitness, as well as whether exercise can counteract the effects of ageing, is still unknown. Therefore, in this study, we aim to investigate the muscle function of both physically active and inactive young and middle-aged individuals. We hypothesise that endurance training can mitigate some of the effects of ageing.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Maximal exercise test

Trials testing the same drug.

Other recruiting trials for Aging

Currently open trials in the same condition.

Other VU University of Amsterdam trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06539078.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing